Skip to main content
Scheme 1 | Journal of Nanobiotechnology

Scheme 1

From: Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC

Scheme 1

Schematic illustration of Asp8-modified RBC-H hybrid membrane-coated H40-TPZ/IR780 NPs for enhancing photothermal and chemotherapy of bone invasion by OSCC. a Preparation of the Asp8[H40-TPZ/IR780@(RBC-H)] nanoparticle. b Targeting delivery TPZ and IR780 to bone invasion site by the resulting nanoparticle for enhancing photothermal and hypoxia-activated synergistic chemotherapy effects in vivo

Back to article page